Providence Therapeutics Inc.
Profile
Mailing Address: 140 Sunhaven Close SE
Calgary, Alberta
T2X 2V9
Head Office Address: 140 Sunhaven Close SE
Calgary, Alberta
T2X 2V9
Contact Name: Brad Sorenson Principal Regulator: Non-Reporting Issuer
Business e-mail address: brad@providencetherapeutics.com Short Form Prospectus Issuer: No
Telephone Number: 403 909-4532 Reporting Jurisdictions: Non-Reporting Issuer
Fax Number: Stock Exchange: N/A
Date of Formation: Jun 12 2015 Stock Symbol:
Jurisdiction Where Formed: Alberta Auditor: N/A
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: Transfer Agent:
Financial Year-End: Dec 31 Size of Issuer (Assets): Under $5,000,000


View This Company's Documents